98 related articles for article (PubMed ID: 4032756)
1. [SM-108].
Uzuka Y; Saito Y
Gan No Rinsho; 1985 May; 31(6 Suppl):757-66. PubMed ID: 4032756
[TBL] [Abstract][Full Text] [Related]
2. [Transition of criteria for the determination of efficacy of cancer chemotherapy].
Koyama Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):153-63. PubMed ID: 3942397
[No Abstract] [Full Text] [Related]
3. [Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
Nakamura M; Fukui M; Morisada S; Inaba M; Tsukagoshi S; Sakurai Y
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2030-6. PubMed ID: 4051519
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) in hematological malignancies].
Kimura K; Yamada K; Uzuka Y; Masaoka T; Hirano M; Ohno R; Ogawa M
Gan To Kagaku Ryoho; 1989 Jan; 16(1):123-30. PubMed ID: 2643392
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment schedule and antitumor spectrum of 4-carbamoylimidazolium 5-olate (SM-108) in murine tumors.
Yoshida N; Nakamura M; Fukui M; Morisada S; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Dec; 43(12 Pt 1):5851-6. PubMed ID: 6640536
[TBL] [Abstract][Full Text] [Related]
6. Combination phase 1-II study of imidazole carboxamide (NCS45388).
Wagner DE; Ramirez G; Weiss AJ; Hill G
Oncology; 1972; 26(2):310-6. PubMed ID: 5049924
[No Abstract] [Full Text] [Related]
7. [Treatment of myelodysplastic syndrome using SM-108 in relation to stem cell kinetics].
Uzuka Y; Saito Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1215-22. PubMed ID: 3382196
[TBL] [Abstract][Full Text] [Related]
8. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
Kingra GS; Comis R; Olson KB; Horton J
Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
[No Abstract] [Full Text] [Related]
9. [Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].
Kimura K; Suzuoki Y; Ogawa M; Miyazaki T; Uzuka Y; Sakai Y; Ohno R; Yamada K; Ota K; Yoshida T
Gan To Kagaku Ryoho; 1989 Jan; 16(1):113-21. PubMed ID: 2643391
[TBL] [Abstract][Full Text] [Related]
10. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.
Carter SK
J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496
[No Abstract] [Full Text] [Related]
11. [Administration of dicarbamin in the course of taxotere-assisted chemotherapy].
Koroleva IA; Mochalova AS
Vopr Onkol; 2011; 57(2):250, 252-4. PubMed ID: 21809675
[No Abstract] [Full Text] [Related]
12. [6-methylprednisolone acetate (6-MPA): an alternative treatment in oncology].
Azzoni P; Dal Negro R; Turco P
Minerva Med; 1978 Sep; 69(42):2861-7. PubMed ID: 278910
[No Abstract] [Full Text] [Related]
13. Anticancer Chinese herbal medicines.
Yeh SD
Am J Chin Med (Gard City N Y); 1973 Jul; 1(2):271-4. PubMed ID: 4359508
[No Abstract] [Full Text] [Related]
14. [Phase I study of SM-5887, a new anthracycline derivative].
Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1988 May; 15(5):1771-6. PubMed ID: 3369871
[TBL] [Abstract][Full Text] [Related]
15. Navelbine: a new step in cancer therapy?
Armand JP; Marty M
Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
[No Abstract] [Full Text] [Related]
16. [Clinical trial of SM-108 in myeloproliferative disorders].
Nishikawa M; Morita K; Sekine T; Takeda M; Tamaki S; Katayama N; Kobayashi T; Mukai K; Tanaka H; Minami N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3078-82. PubMed ID: 3314714
[TBL] [Abstract][Full Text] [Related]
17. [Phase I and pharmacokinetic study of SM-5887 by 5-day schedule].
Inoue K; Matsumura A; Horikoshi N; Aiba K; Mukaiyama T; Matsumura T; Ogihara A; Sumida T; Ogawa M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):477-82. PubMed ID: 1558397
[TBL] [Abstract][Full Text] [Related]
18. [Antitumoral chemotherapy].
Drochmans A
Acta Clin Belg; 1974; 29(1):1-19. PubMed ID: 4596845
[No Abstract] [Full Text] [Related]
19. Induction of erythroid differentiation of K562 cells by 4-carbamoylimidazolium 5-olate (SM-108).
Hata Y; Yamaji Y; Shiotani T; Fujita J; Kamano H; Ikeda K; Takahara J; Irino S
Biochem Pharmacol; 1991 Nov; 42(12):2307-12. PubMed ID: 1684898
[TBL] [Abstract][Full Text] [Related]
20. The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.
Hanauske AR; Hanauske U; Von Hoff DD
Curr Probl Cancer; 1985 Dec; 9(12):1-66. PubMed ID: 2419036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
